L. Taylor

发表

Quantification of dystrophin immunofluorescence in dystrophinopathy muscle specimens

K. Flanigan, C. Rodesch, Y. Kaminoh, 2012, Neuropathology and applied neurobiology.

Nonsense mutation‐associated Becker muscular dystrophy: interplay between exon definition and splicing regulatory elements within the DMD gene

R. Finkel, B. Wong, A. Pestronk, 2011, Human mutation.

Clinical and genetic characterization of manifesting carriers of DMD mutations

R. Finkel, B. Wong, A. Pestronk, 2010, Neuromuscular Disorders.

The ZZ Domain of Dystrophin in DMD: Making Sense of Missense Mutations

K. Flanigan, J. Ervasti, A. Vulin, 2014, Human mutation.

Sustained alpha-sarcoglycan gene expression following gene transfer in LGMD 2 D

B. Byrne, J. Mendell, Clark, 2011 .

Sustained alpha‐sarcoglycan gene expression after gene transfer in limb‐girdle muscular dystrophy, type 2D

B. Byrne, J. Gastier-Foster, J. Mendell, 2010, Annals of neurology.

Dystrophin quantification

F. Muntoni, K. Flanigan, K. Anthony, 2014, Neurology.

Clinical phenotypes as predictors of the outcome of skipping around DMD exon 45

R. Finkel, A. Pestronk, J. Mendell, 2015, Annals of neurology.